X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (159) 159
index medicus (135) 135
female (134) 134
oncology (55) 55
adult (52) 52
middle aged (52) 52
cancer (47) 47
cervical cancer (44) 44
aged (36) 36
obstetrics & gynecology (33) 33
obstetrics and gynecology (33) 33
expression (32) 32
male (31) 31
animals (30) 30
cell line, tumor (28) 28
analysis (27) 27
endometrial cancer (26) 26
immunology (26) 26
mice (26) 26
human papillomavirus (25) 25
prognosis (25) 25
carcinoma (24) 24
health aspects (23) 23
ovarian cancer (23) 23
microbiology (22) 22
pregnancy (22) 22
biochemistry (21) 21
uterine cervical neoplasms - pathology (20) 20
women (20) 20
peptides (19) 19
hygiene (18) 18
uterine cervical neoplasms - virology (18) 18
apoptosis (17) 17
beer (17) 17
blasting (17) 17
care and treatment (17) 17
chemistry (17) 17
compositions thereof (17) 17
culture media (17) 17
enzymology (17) 17
heating (17) 17
human necessities (17) 17
lighting (17) 17
mechanical engineering (17) 17
medical or veterinary science (17) 17
metallurgy (17) 17
microorganisms or enzymes (17) 17
mutation or genetic engineering (17) 17
organic chemistry (17) 17
papillomavirus infections (17) 17
preparations for medical, dental, or toilet purposes (17) 17
propagating, preserving or maintaining microorganisms (17) 17
spirits (17) 17
tumors (17) 17
vinegar (17) 17
weapons (17) 17
wine (17) 17
cervical intraepithelial neoplasia - virology (16) 16
chemotherapy (16) 16
japan (16) 16
medicine (16) 16
reproductive biology (16) 16
endometrial neoplasms - pathology (15) 15
risk factors (15) 15
specific therapeutic activity of chemical compounds ormedicinal preparations (15) 15
cell biology (14) 14
combustion apparatus (14) 14
combustion processes (14) 14
flues (14) 14
gene expression (14) 14
genetic aspects (14) 14
removal or treatment of combustion products or combustionresidues (14) 14
treatment outcome (14) 14
kinases (13) 13
mutation (13) 13
signal transduction (13) 13
studies (13) 13
activation (12) 12
cervical intraepithelial neoplasia (12) 12
endometrial neoplasms - drug therapy (12) 12
flow cytometry (12) 12
inflammation (12) 12
medical prognosis (12) 12
ovarian neoplasms - pathology (12) 12
papillomaviruses (12) 12
surgery (12) 12
virology (12) 12
hematology, oncology and palliative medicine (11) 11
infectious diseases (11) 11
internal medicine (11) 11
medicine, research & experimental (11) 11
metastasis (11) 11
multidisciplinary sciences (11) 11
papillomavirus infections - virology (11) 11
pathway (11) 11
research (11) 11
research article (11) 11
retrospective studies (11) 11
rodents (11) 11
science (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Nihon University Medical Association, ISSN 0029-0424, 08/2019, Volume 78, Issue 4, pp. 257 - 260
Journal Article
Vaccine, ISSN 0264-410X, 06/2018, Volume 36, Issue 24, pp. 3423 - 3426
Therapeutic HPV vaccine is an agent to induce E7-specific Th1 immune responses to treat cervical neoplasia (CIN2-3). Our previous clinical trial has... 
Therapeutic HPV vaccine | Lactobacillus-based vaccine | Human papillomavirus (HPV) | Mucosal immunity | Cervical intraepithelial neoplasia (CIN) | Cervical cancer | MEDICINE, RESEARCH & EXPERIMENTAL | STRATEGY | PHASE-II | IMMUNOLOGY | CERVICAL INTRAEPITHELIAL NEOPLASIA | LESIONS | TRIAL | WOMEN | HIGH-GRADE | CASEI | Dose-Response Relationship, Immunologic | Papillomavirus Vaccines - genetics | Humans | Immunity, Mucosal | Papillomavirus E7 Proteins - immunology | Antigens, Viral - genetics | Human papillomavirus 16 - immunology | Th1 Cells - immunology | Papillomavirus E7 Proteins - genetics | Th1 Cells - virology | Papillomavirus E7 Proteins - secretion | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - immunology | Lactobacillus casei - genetics | Gene Expression | Genetic Vectors - chemistry | Administration, Oral | Immunization - methods | Interferon-gamma - secretion | Mice, Inbred C57BL | Uterine Cervical Neoplasms - prevention & control | Genetic Vectors - metabolism | Uterine Cervical Neoplasms - immunology | Lactobacillus casei - immunology | Cervical Intraepithelial Neoplasia - virology | Antigens, Viral - immunology | Animals | Genetic Engineering | Papillomavirus Infections - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Mice | Transgenes - immunology | Human papillomavirus 16 - genetics | Interferon-gamma - biosynthesis | Flow cytometry | Antigens | Immunization | Immunoglobulins | Immune response | Lactobacilli | Oral administration | Clinical trials | Lymphocytes T | Vaccines | Gene expression | Molecular chains | Optimization | Proteins | Human papillomavirus | γ-Interferon | Binding sites | Immune system
Journal Article
Vaccine, ISSN 0264-410X, 06/2018, Volume 36, Issue 24, p. 3423
Therapeutic HPV vaccine is an agent to induce E7-specific Th1 immune responses to treat cervical neoplasia (CIN2-3). Our previous clinical trial has... 
Papillomaviruses | Medical colleges | Immune response | Vaccines | Papillomavirus infections | Obstetrics | Cervical cancer
Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 18, pp. 2291 - 2292
In light of several changes that have occurred in Japan since 2015, including an improved understanding of the rare adverse events associated with these... 
Allergy and Immunology | MEDICINE, RESEARCH & EXPERIMENTAL | WOMEN | CERVICAL LESIONS | IMMUNOLOGY | PROGRAM | Papillomavirus infections | Vaccines | Immunization | Abnormalities | Vaccination | Overseas | Population studies | Cervix | Promotion | Learned societies | Institutions | Incidence | Human papillomavirus | Councils | Womens health | Consultation | Lesions | Drug dosages | Cervical cancer
Journal Article
Japanese Journal of Infectious Diseases, ISSN 1344-6304, 03/2016, Volume 69, Issue 2, pp. 151 - 153
Journal Article
Uirusu, ISSN 0042-6857, 06/2012, Volume 62, Issue 1, p. 79
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 47, pp. 6233 - 6239
Journal Article
Journal Article
Uirusu, ISSN 0042-6857, 2012, Volume 62, Issue 1, pp. 79 - 86
Journal Article
Journal of Reproductive Immunology, ISSN 0165-0378, 11/2017, Volume 124, pp. 85 - 85
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, p. e37431
The PI3K (phosphatidylinositol-3-kinase)/mTOR (mammalian target of rapamycin) pathway is frequently activated in endometrial cancer through various... 
CANCER-CELLS | PI3K | EVEROLIMUS | PIK3CA | BIOLOGY | HIGH-FREQUENCY | RAPAMYCIN INHIBITOR | MUTATIONS | ANTITUMOR-ACTIVITY | PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET | RENAL-CELL CARCINOMA | ras Proteins - genetics | Ribosomal Protein S6 Kinases - metabolism | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | Imidazoles - administration & dosage | Glycogen Synthase Kinase 3 beta | Antineoplastic Agents - administration & dosage | Phosphoproteins - metabolism | Quinolines - administration & dosage | Quinolines - pharmacology | Dose-Response Relationship, Drug | TOR Serine-Threonine Kinases - antagonists & inhibitors | Endometrial Neoplasms - genetics | Female | Antineoplastic Agents - pharmacology | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Everolimus | PTEN Phosphohydrolase - genetics | Sirolimus - analogs & derivatives | Genotype | Imidazoles - pharmacology | Glycogen Synthase Kinase 3 - metabolism | Sirolimus - pharmacology | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Sirolimus - administration & dosage | Animals | Class I Phosphatidylinositol 3-Kinases | MAP Kinase Signaling System - drug effects | Mice, Nude | Cell Line, Tumor | Endometrial Neoplasms - drug therapy | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Mutation | Adaptor Proteins, Signal Transducing - metabolism | G1 Phase Cell Cycle Checkpoints - drug effects | Genetic aspects | B cells | Endometrial cancer | Cancer | TOR protein | Biotechnology | Carcinoma | MAP kinase | AKT protein | Rapamycin | Tumor cell lines | Kinases | K-Ras protein | 1-Phosphatidylinositol 3-kinase | Anticancer properties | Alterations | Inhibitors | Antitumor activity | Hormone replacement therapy | Endometrium | PTEN protein
Journal Article